URGN
UroGen Pharma Ltd
NASDAQ: URGN · HEALTHCARE · BIOTECHNOLOGY
$23.83
+2.10% today
Updated 2026-04-30
Market cap
$1.14B
P/E ratio
—
P/S ratio
10.35x
EPS (TTM)
$-3.19
Dividend yield
—
52W range
$3 – $30
Volume
0.8M
UroGen Pharma Ltd (URGN) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $17.53M | $8.16M | $1.13M | $18000.00 | $11.80M | $48.04M | $64.36M | $82.71M | $90.40M | $109.79M |
| Revenue growth (YoY) | — | — | — | — | -53.5% | -86.2% | -98.4% | +65450.0% | +307.2% | +34.0% | +28.5% | +9.3% | +21.4% |
| Cost of revenue | $0.00 | $0.00 | $113000.00 | $28000.00 | $600000.00 | $1.80M | $48000.00 | $1.01M | $5.16M | $7.65M | $9.36M | $8.88M | $12.45M |
| Gross profit | $0.00 | $0.00 | $-113000.00 | $17.50M | $7.56M | $-675000.00 | $18000.00 | $10.79M | $42.88M | $56.70M | $73.35M | $81.52M | $97.34M |
| Gross margin | — | — | — | 99.8% | 92.6% | -59.8% | 100.0% | 91.4% | 89.3% | 88.1% | 88.7% | 90.2% | 88.7% |
| R&D | $2.33M | $4.01M | $10.52M | $10.29M | $18.70M | $36.93M | $49.30M | $47.31M | $47.64M | $52.91M | $45.61M | $57.15M | $67.11M |
| SG&A | $1.05M | $890000.00 | $1.90M | $6.42M | $8.81M | $39.57M | $60.20M | $90.22M | $39.94M | $82.84M | $90.36M | $121.15M | $155.10M |
| Operating income | $-3.39M | $-4.37M | $-12.41M | $798000.00 | $-19.95M | $-77.18M | $-109.48M | $-126.74M | $-92.29M | $-79.04M | $-65.54M | $-96.78M | $-124.86M |
| Operating margin | — | — | — | 4.6% | -244.5% | -6842.2% | -608211.1% | -1074.2% | -192.1% | -122.8% | -79.2% | -107.1% | -113.7% |
| EBITDA | $-3.37M | $-4.34M | $-12.30M | $1.01M | $-19.74M | $-76.76M | $-108.15M | $-124.69M | $-91.46M | $-76.21M | $-60.35M | $-95.35M | $-135.66M |
| EBITDA margin | — | — | — | 5.8% | -242.0% | -6805.2% | -600855.6% | -1056.8% | -190.4% | -118.4% | -73.0% | -105.5% | -123.6% |
| EBIT | $-3.39M | $-4.37M | $-12.41M | $798000.00 | $-19.95M | $-77.18M | $-109.48M | $-126.74M | $-92.29M | $-78.03M | $-62.06M | $-95.68M | $-138.07M |
| Interest expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $284000.00 | $3.67M | $17.44M | $8.44M | $14.71M | $12.52M | $33.85M |
| Income tax | $0.00 | $81000.00 | $0.00 | $0.00 | $19000.00 | $125000.00 | $-4.62M | $3.37M | $1.45M | $1.75M | $3.92M | $2.83M | — |
| Effective tax rate | 0.0% | -1.8% | 0.0% | 0.0% | -0.1% | -0.2% | 4.2% | -2.7% | -1.3% | -1.6% | -4.0% | -2.3% | 0.0% |
| Net income | $-3.31M | $-4.56M | $-12.69M | $-1.94M | $-20.00M | $-75.66M | $-105.15M | $-128.48M | $-110.82M | $-109.78M | $-102.24M | $-126.87M | $-153.49M |
| Net income growth (YoY) | — | -37.8% | -178.5% | +84.7% | -930.4% | -278.3% | -39.0% | -22.2% | +13.7% | +0.9% | +6.9% | -24.1% | -21.0% |
| Profit margin | — | — | — | -11.1% | -245.2% | -6707.2% | -584144.4% | -1088.9% | -230.7% | -170.6% | -123.6% | -140.4% | -139.8% |